PGHL
Procter & Gamble Health
Each stock's 10,000-path forecast, rendered as light.
Procter & Gamble Health (PGHL) Stock Analysis & Case Study
Is PGHL a good buy? The data-driven verdict.
on the numbers it worth a closer look, a Downstox Snapshot Score of 61/100.
On the numbers, Procter & Gamble Health (PGHL) worth a closer look, a Downstox Snapshot Score of 61/100, weighing a 63% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
PGHL share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of PGHL history (11%/yr drift, 25%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| PGHL 2027 | ₹4,961 | ₹6,769 | ₹9,261 | +8% |
| PGHL 2028 | ₹4,700 | ₹7,319 | ₹11,540 | +17% |
| PGHL 2029 | ₹4,660 | ₹7,946 | ₹13,716 | +27% |
| PGHL 2030 | ₹4,636 | ₹8,634 | ₹16,168 | +38% |
| PGHL 2031 | ₹4,665 | ₹9,336 | ₹18,905 | +50% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability PGHL goes up, or doubles?
The bull case for PGHL
- A 10,000-path probability model puts a 63% chance the price is higher in a year, with a median target of ₹6,769 (+8%).
- Relatively low volatility (25%/yr), a steadier ride than the typical mid/small-cap.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹13,716.
The bear case & risks
- No model or past record guarantees future returns, treat this as one input, not a decision.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹4,660.
PGHL volatility & expected range, how bumpy is the ride?
Over the last 2.0 years PGHL compounded at 11%/year with annualized volatility of 25%. That volatility implies a 1-year 80% range of ₹4,961–₹9,261, the honest backbone behind any single price target.
PGHL price forecast, the full 60-month probability fan
PGHL price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds PGHL hits common targets within the simulated horizon?
Full multi-horizon detail on the PGHL price target & forecast page.
PGHL MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy PGHL with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 27.2% | 3.7× |
| DhanCHEAPEST | 27.2% | 3.7× |
Compare every broker on the PGHL MTF page.
PGHL vs peers,sector comparison
About Procter & Gamble Health: sector, index & market-cap context
Procter & Gamble Health (PGHL) is an NSE-listed company.
How the PGHL Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Procter & Gamble Health's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
PGHL analysis, FAQs
Is Procter & Gamble Health (PGHL) a good buy?
On the numbers, Procter & Gamble Health (PGHL) worth a closer look, a Downstox Snapshot Score of 61/100, weighing a 63% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is PGHL overvalued or undervalued?
Valuation ratios for PGHL are tracked live on Downstox.
What is the PGHL share price target for 2031?
PGHL's probability-weighted 2031 median target is ₹9,336, with an 80% range of ₹4,665–₹18,905 (10,000-path Monte-Carlo).
What is the probability PGHL doubles in 5 years?
The modelled probability of PGHL reaching ₹12,488 (2×) within 5 years is 30%.
What is the bull case for PGHL?
A 10,000-path probability model puts a 63% chance the price is higher in a year, with a median target of ₹6,769 (+8%). Relatively low volatility (25%/yr), a steadier ride than the typical mid/small-cap.
What are the risks in PGHL?
No model or past record guarantees future returns, treat this as one input, not a decision.